JENNIFER YOUNG: Open Payments
NPI 1093063380 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,271 in 139 payments from 20 companies in 2025. Trend: 2023 $4,887 · 2024 $6,342 · 2025 $3,271
Food & beverage: $3,116Education: $155
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $745 |
| UCB, Inc. | 21 | $529 |
| Janssen Biotech, Inc. | 13 | $457 |
| Novartis Pharmaceuticals Corporation | 15 | $295 |
| Amgen Inc. | 14 | $239 |
| AstraZeneca Pharmaceuticals LP | 7 | $170 |
| PFIZER INC. | 10 | $163 |
| GlaxoSmithKline, LLC. | 7 | $142 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $133 |
| Mallinckrodt Hospital Products Inc. | 3 | $86 |
Products named: Bimzelx, RINVOQ, TREMFYA, COSENTYX, SKYRIZI, XELJANZ, BENLYSTA, SAPHNELO.
Industry payments across GA — which companies pay providers there.
